Suzuken Co., Ltd. (SZUKF)
USD 30.3
(0.0%)
USD 30.3
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -1.17 Billion USD | -69.58% |
| 2023 | -790.86 Million USD | 29.73% |
| 2022 | -1.12 Billion USD | 25.33% |
| 2021 | -1.5 Billion USD | 5.76% |
| 2020 | -1.59 Billion USD | 17.47% |
| 2019 | -1.93 Billion USD | -4.23% |
| 2018 | -1.85 Billion USD | -85.81% |
| 2017 | -1 Billion USD | -5.86% |
| 2016 | -945.15 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q4 | -1.17 Billion USD | -14.68% |
| 2024 Q2 | -1.34 Billion USD | -98.58% |
| 2024 Q1 | -626.91 Million USD | 15.61% |
| 2024 FY | -1.17 Billion USD | -48.66% |
| 2024 Q3 | -1.11 Billion USD | 12.64% |
| 2023 Q4 | -790.86 Million USD | 28.77% |
| 2023 Q2 | -750.73 Million USD | 6.07% |
| 2023 Q1 | -799.22 Million USD | 28.99% |
| 2023 FY | -790.86 Million USD | 29.73% |
| 2023 Q3 | -1.11 Billion USD | -47.89% |
| 2022 Q3 | -1.61 Billion USD | -52.84% |
| 2022 Q2 | -1.05 Billion USD | 1.82% |
| 2022 Q1 | -1.07 Billion USD | 28.54% |
| 2022 FY | -1.12 Billion USD | 25.33% |
| 2022 Q4 | -1.12 Billion USD | 30.36% |
| 2021 Q4 | -1.5 Billion USD | 0.0% |
| 2021 FY | -1.5 Billion USD | 5.76% |
| 2020 FY | -1.59 Billion USD | 17.47% |
| 2019 FY | -1.93 Billion USD | -4.23% |
| 2018 FY | -1.85 Billion USD | -85.81% |
| 2017 FY | -1 Billion USD | -5.86% |
| 2016 FY | -945.15 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| China Medicine Corporation | 9.03 Million USD | 13113.267% |
| DH Enchantment Inc. | 409.44 Thousand USD | 287237.32% |
| Exlites Holdings International, Inc. | - USD | Infinity% |
| Itonis, Inc. | 909.99 Thousand USD | 129294.724% |
| One Step Vending Corp. | 247.1 Thousand USD | 475871.485% |
| MediPal Holdings Corporation | -1.49 Billion USD | 21.482% |
| PD-Rx Pharmaceuticals, Inc. | -6.83 Million USD | -17104.458% |
| Pharmagen, Inc. | 4362.26 USD | 26951024.544% |